{"id":4184,"date":"2025-01-27T08:05:33","date_gmt":"2025-01-27T08:05:33","guid":{"rendered":"https:\/\/cbmeds.in\/?p=4184"},"modified":"2025-01-27T08:05:33","modified_gmt":"2025-01-27T08:05:33","slug":"monoclonal-antibodies-in-multiple-sclerosis-a-path-to-better-control","status":"publish","type":"post","link":"https:\/\/cbmeds.in\/?p=4184","title":{"rendered":"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the body\u2019s immune system attacking the protective sheath (myelin) that covers nerve fibers. This can disrupt nerve signals, leading to symptoms such as muscle weakness, fatigue, and vision problems. Over the past decade, monoclonal antibodies (MABs)<\/strong> have emerged as a powerful tool in the fight against MS, transforming the management of this complex condition.<\/p>\n\n\n\n

One of the key benefits of monoclonal antibodies is their ability to reduce relapse rates and flares<\/strong>. Relapses\u2014sudden worsening of symptoms\u2014are often triggered when the immune system attacks myelin. MABs work by targeting specific immune cells or inflammatory molecules, effectively preventing these harmful attacks. As a result, people with MS can experience fewer and less severe relapses over time, helping them maintain a steadier state of health.<\/p>\n\n\n\n

Beyond controlling relapses, MABs also slow disease progression<\/strong>. By suppressing inflammation and preventing further immune damage, these therapies can help preserve nerve function. For those living with MS, slowing or halting the progression of disability is a significant victory. It means retaining mobility, independence, and overall quality of life for a longer period.<\/p>\n\n\n\n

Finally, MABs protect healthy nerve cells<\/strong> from ongoing immune-mediated damage. When immune attacks occur in MS, not all nerve cells are damaged equally. Some may remain unscathed\u2014but at risk. By specifically targeting and blocking the key mechanisms behind these attacks, MABs help shield the remaining healthy nerve cells, reducing the overall disease burden.<\/p>\n\n\n\n

For many, monoclonal antibodies have opened new doors in MS treatment and management. With continued research, these therapies will likely become more precise and personalized, offering hope to those living with a diagnosis once believed to have limited treatment options. As we learn more, we move closer to a future where people with MS can truly thrive despite the challenges of this complex disease.<\/p>\n","protected":false},"excerpt":{"rendered":"

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the body\u2019s immune system attacking the protective sheath (myelin) that covers nerve fibers. This can disrupt nerve signals, leading to symptoms such as muscle weakness, fatigue, and vision problems. Over the past decade, monoclonal antibodies (MABs) have emerged as a powerful tool in the fight […]<\/p>\n","protected":false},"author":2,"featured_media":4185,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nMonoclonal Antibodies in Multiple Sclerosis: A Path to Better Control - Curiance Biotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cbmeds.in\/?p=4184\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control - Curiance Biotech\" \/>\n<meta property=\"og:description\" content=\"Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the body\u2019s immune system attacking the protective sheath (myelin) that covers nerve fibers. This can disrupt nerve signals, leading to symptoms such as muscle weakness, fatigue, and vision problems. Over the past decade, monoclonal antibodies (MABs) have emerged as a powerful tool in the fight […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cbmeds.in\/?p=4184\" \/>\n<meta property=\"og:site_name\" content=\"Curiance Biotech\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-27T08:05:33+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/cbmeds.in\/wp-content\/uploads\/2025\/01\/happy-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/person\\\/4e7dce38d197111ae0c614cbeef78e85\"},\"headline\":\"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control\",\"datePublished\":\"2025-01-27T08:05:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184\"},\"wordCount\":315,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/happy-3.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cbmeds.in\\\/?p=4184#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184\",\"name\":\"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control - Curiance Biotech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/happy-3.jpg\",\"datePublished\":\"2025-01-27T08:05:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cbmeds.in\\\/?p=4184\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#primaryimage\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/happy-3.jpg\",\"contentUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/happy-3.jpg\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?p=4184#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cbmeds.in\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#website\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/\",\"name\":\"cbmeds.in\",\"description\":\"Tomorrow's Medicine Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\"},\"alternateName\":\"Curiance Biotech\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cbmeds.in\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\",\"name\":\"CB Meds\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-1-1-1.png\",\"contentUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-1-1-1.png\",\"width\":640,\"height\":640,\"caption\":\"CB Meds\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/person\\\/4e7dce38d197111ae0c614cbeef78e85\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/15fd88a826785cafc6f8817a828358e8c21fe40ba0e884a6b4c496258f3bfcf1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/15fd88a826785cafc6f8817a828358e8c21fe40ba0e884a6b4c496258f3bfcf1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/15fd88a826785cafc6f8817a828358e8c21fe40ba0e884a6b4c496258f3bfcf1?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\\\/\\\/cbmeds.in\\\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control - Curiance Biotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cbmeds.in\/?p=4184","og_locale":"en_US","og_type":"article","og_title":"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control - Curiance Biotech","og_description":"Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the body\u2019s immune system attacking the protective sheath (myelin) that covers nerve fibers. This can disrupt nerve signals, leading to symptoms such as muscle weakness, fatigue, and vision problems. Over the past decade, monoclonal antibodies (MABs) have emerged as a powerful tool in the fight […]","og_url":"https:\/\/cbmeds.in\/?p=4184","og_site_name":"Curiance Biotech","article_published_time":"2025-01-27T08:05:33+00:00","og_image":[{"width":1080,"height":1080,"url":"http:\/\/cbmeds.in\/wp-content\/uploads\/2025\/01\/happy-3.jpg","type":"image\/jpeg"}],"author":"Admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cbmeds.in\/?p=4184#article","isPartOf":{"@id":"https:\/\/cbmeds.in\/?p=4184"},"author":{"name":"Admin","@id":"https:\/\/cbmeds.in\/#\/schema\/person\/4e7dce38d197111ae0c614cbeef78e85"},"headline":"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control","datePublished":"2025-01-27T08:05:33+00:00","mainEntityOfPage":{"@id":"https:\/\/cbmeds.in\/?p=4184"},"wordCount":315,"commentCount":0,"publisher":{"@id":"https:\/\/cbmeds.in\/#organization"},"image":{"@id":"https:\/\/cbmeds.in\/?p=4184#primaryimage"},"thumbnailUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/01\/happy-3.jpg","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cbmeds.in\/?p=4184#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cbmeds.in\/?p=4184","url":"https:\/\/cbmeds.in\/?p=4184","name":"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control - Curiance Biotech","isPartOf":{"@id":"https:\/\/cbmeds.in\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cbmeds.in\/?p=4184#primaryimage"},"image":{"@id":"https:\/\/cbmeds.in\/?p=4184#primaryimage"},"thumbnailUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/01\/happy-3.jpg","datePublished":"2025-01-27T08:05:33+00:00","breadcrumb":{"@id":"https:\/\/cbmeds.in\/?p=4184#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cbmeds.in\/?p=4184"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbmeds.in\/?p=4184#primaryimage","url":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/01\/happy-3.jpg","contentUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/01\/happy-3.jpg","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/cbmeds.in\/?p=4184#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cbmeds.in\/"},{"@type":"ListItem","position":2,"name":"Monoclonal Antibodies in Multiple Sclerosis: A Path to Better Control"}]},{"@type":"WebSite","@id":"https:\/\/cbmeds.in\/#website","url":"https:\/\/cbmeds.in\/","name":"cbmeds.in","description":"Tomorrow's Medicine Today","publisher":{"@id":"https:\/\/cbmeds.in\/#organization"},"alternateName":"Curiance Biotech","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cbmeds.in\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cbmeds.in\/#organization","name":"CB Meds","url":"https:\/\/cbmeds.in\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbmeds.in\/#\/schema\/logo\/image\/","url":"https:\/\/cbmeds.in\/wp-content\/uploads\/2023\/09\/Logo-1-1-1.png","contentUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2023\/09\/Logo-1-1-1.png","width":640,"height":640,"caption":"CB Meds"},"image":{"@id":"https:\/\/cbmeds.in\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cbmeds.in\/#\/schema\/person\/4e7dce38d197111ae0c614cbeef78e85","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/15fd88a826785cafc6f8817a828358e8c21fe40ba0e884a6b4c496258f3bfcf1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/15fd88a826785cafc6f8817a828358e8c21fe40ba0e884a6b4c496258f3bfcf1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/15fd88a826785cafc6f8817a828358e8c21fe40ba0e884a6b4c496258f3bfcf1?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/cbmeds.in\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/posts\/4184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4184"}],"version-history":[{"count":1,"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/posts\/4184\/revisions"}],"predecessor-version":[{"id":4186,"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/posts\/4184\/revisions\/4186"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/media\/4185"}],"wp:attachment":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}